SAIBA

saiba-logo

At Saiba GmbH they develop cutting-edge therapeutic and prophylactic vaccines and their vision is to become a leading innovation provider to the vaccines industry. Built on a solid foundation of experience, know-how, and intellectual property, Saiba GmbH can help you define, explore, and develop vaccination strategies for your needs.

#SimilarOrganizations #Website #More

SAIBA

Industry:
Biotechnology Health Care Therapeutics

Founded:
2012-01-01

Address:
Ramismuhle, Zurich, Switzerland

Country:
Switzerland

Website Url:
http://www.saiba-biotech.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome ReCAPTCHA WordPress 6.0 Gravity Forms


Similar Organizations

cahaba-pharmaceuticals-logo

Cahaba Pharmaceuticals

Cahaba Pharmaceuticals develops novel therapeutics and supportive care products for cancer patients.

galenea-logo

Galenea

Galenea is engaged in developing therapeutics for central nervous system diseases.

not_available_image

Progenteq

Progenteq develops cartilage repair therapy to regenerate damaged cartilage.

Official Site Inspections

http://www.saiba-biotech.com

  • Host name: 167.99.141.97
  • IP address: 167.99.141.97
  • Location: Frankfurt am Main Germany
  • Latitude: 50.1188
  • Longitude: 8.6843
  • Timezone: Europe/Berlin
  • Postal: 60313

Loading ...

More informations about "Saiba"

Saiba Biotech โ€“ Harnessing the power of vaccination

The founder of Saiba AG combines unique expertise in biotech, vaccinology and immunology. Saiba AG combines unique knowhow from biotech as well as basic research. In addition to โ€ฆSee details»

Saiba - Crunchbase Company Profile & Funding

Contact Email [email protected]; At Saiba GmbH they develop cutting-edge therapeutic and prophylactic vaccines and their vision is to become a leading innovation provider to the โ€ฆSee details»

Who We Are - Saiba Biotech

Dr. Mona O. Mohsen obtained her B.Sc. and M.Sc. degree in biomedical science from Qatar University (2015). She โ€ฆSee details»

Saiba AG Selects AGC Biologics to Develop and Produce COVID โ€ฆ

Jun 16, 2020 Learn more at www.saiba-biotech.com. About AGC Biologics: AGC Biologics is a leading global Contract Development and Manufacturing Organization (CDMO) with a strong โ€ฆSee details»

Saiba AG - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Saiba AG of Pfäffikon, SCHWYZ. Get the latest business insights from Dun & Bradstreet.See details»

Saiba AG - Swiss Biotech

Saiba AG . Swiss Biotech Association ... Type of organization. Private company. Year of foundation. 2012. ... We provide DCS & MES solutions, CQV, operational readiness, and โ€ฆSee details»

Saiba Biotech - Products, Competitors, Financials, Employees ...

Saiba Biotech is a biotechnology company focused on the development of novel vaccines for unmet medical needs in the healthcare sector. The company's main offerings include vaccines โ€ฆSee details»

Saiba - Overview, News & Similar companies | ZoomInfo.com

Jun 16, 2020 View Saiba (www.saiba-biotech.com) location in Zurich, Switzerland , revenue, industry and description. Find related and similar companies as well as employees by title and โ€ฆSee details»

Saiba Animal Health 2025 Company Profile: Valuation, Investors ...

Saiba Biotech, Hypo Pet. Ownership Status. Acquired/Merged (Operating Subsidiary) Financing Status. Formerly VC-backed. Corporate Office. Wagistrasse 12; Schlieren; 8952 Zurich; ...See details»

Boehringer Ingelheim acquires Saiba Animal Health, adding โ€ฆ

Saiba Animal Healthโ€™s innovative technology platform uses a first-of-its-kind therapeutic vaccine approach, which is designed to create an immune response, targeting chronic diseases such โ€ฆSee details»

Saiba GmbH - VentureRadar

Oravax Medical United Kingdom Privately Held Oravax Medical Inc. was established in 2021 by Oramed Pharmaceuticals Inc., the largest shareholder in Oravax, along with Premas Biotech, โ€ฆSee details»

Saiba AG Selects AGC Biologics to Develop and Produce ... - Saiba โ€ฆ

Jun 16, 2020 Learn more at www.www.saiba-biotech.com. About AGC Biologics: AGC Biologics is a leading global Contract Development and Manufacturing Organization (CDMO) with a โ€ฆSee details»

Contact - Saiba Biotech

Saiba AG Bahnhofstr. 13 CH-8808 Pfaeffikon Switzerland. To get in touch about our research or specific products, please complete and submit the form below:See details»

Saiba GmbH - startupticker.ch

Sep 4, 2020 Saiba GmbH We use virally shaped nanoparticles as a scaffold for the generation of tailor-made vaccines. The nanoparticle base of the vaccines tricks the immune system into โ€ฆSee details»

Saiba Animal Health joins Boehringer Ingelheim - startupticker.ch

Apr 9, 2024 Saiba Animal Healthโ€™s innovative technology platform uses a first-of-its-kind, patented therapeutic vaccine platform, designed to create an immune response, targeting โ€ฆSee details»

Saiba GmbH - Drug pipelines, Patents, Clinical trials - Synapse

Last update 23 Jan 2025. Saiba GmbH. Private Company |See details»

Latest - Saiba Biotech

Saiba AG has decided to focus on optimization of its vaccine candidate rather than rush into clinical studies in 2020. Read More. September 3, 2020 Allergy Therapeutics secures virus โ€ฆSee details»

Boehringer Ingelheim obtains exclusive rights for Saiba Animal โ€ฆ

Jun 13, 2023 F ounded as a spin-off company from the University of Zürich, Saiba Animal Health AG has developed a novel and innovative virus-like particle (VLP) vaccine nanotechnology โ€ฆSee details»

Our Technology โ€“ Saiba Biotech

We use virally shaped nanoparticles as a scaffold for the generation of tailor-made vaccines. The nanoparticle base of the vaccines tricks the immune system into believing to be under viral โ€ฆSee details»

Saiba AG focuses on a future COVID-19 vaccine with advantages โ€ฆ

Sep 16, 2020 Pfäffikon (SZ): Saiba AG has decided to focus on optimization of its vaccine candidate rather than rush into clinical studies in 2020. Saibaโ€™s strategy is driven by an โ€ฆSee details»

linkstock.net © 2022. All rights reserved